Abstract: The plasma protein:fibrinogen (PP:F) ratio was introduced to aid interpretation of hyperfibrinogenemia by accounting for dehydration. However, this ratio is inconsistently assessed in practice and its clinical value remains unknown. Our objective was to determine whether the PP:F ratio provides additional information in adult horses beyond fibrinogen concentration alone. Two databases were reviewed to identify 412 hyperfibrinogenemic horses. Plasma protein:fibrinogen ratios were calculated and their interpretation compared to the fibrinogen concentration. Ratios < 15 were supportive of inflammation. Albumin and total protein concentrations were evaluated when ratios were ≥ 15 to determine if inflammation was supported. Very good agreement (86%) was found on the presence of inflammation when PP:F ratios were compared to fibrinogen concentration. In 72% of cases in which PP:F ratios did not support inflammation, inflammation was considered likely based on albumin and total protein. These findings suggest that PP:F ratios do not provide additional information in horses over fibrinogen concentrations alone. Le ratio plasma protéine: fibrinogène (PP:F) a été introduit pour aider à l’interprétation de l’hyperfibrinogénémie lors d’hémoconcentration. Toutefois, la valeur clinique de ce ratio est inconnue. Notre objectif était de déterminer si le ratio amène une information additionnelle comparé au fibrinogène. Deux bases de données ont été revues pour identifier 412 chevaux hyperfibrinogénémiques. Le ratio a été calculé et son interprétation comparée à celle du fibrinogène. Les ratios < 15 suggèrent l’inflammation. Pour les cas présentant un ratio ≥ 15, la concentration en albumine et protéines totales a été revue pour voir si l’inflammation était possible. Nos résultats indiquent que dans 86 % des cas, le ratio et le fibrinogène suggèrent la présence d’inflammation. Pour 72 % des cas où le ratio ne suggère pas l’inflammation, cette dernière est considérée probable étant donné la concentration en protéines totales et albumine. Ces résultats suggèrent que le ratio PP:F n’apporte pas d’information supplémentaire comparé au fibrinogène.(Traduit par les auteurs).
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The research explores whether the plasma protein:fibrinogen ratio in horses imparts additional data beyond fibrinogen concentration alone. The study found that this ratio generally doesn’t provide any extra information beyond fibrinogen concentrations.
Research Objective
The primary goal of this research was to discern if the plasma protein:fibrinogen (PP:F) ratio offers more information than the fibrinogen concentration alone in adult horses. This ratio is typically utilized to interpret hyperfibrinogenemia, a condition characterized by elevated levels of fibrinogen in the blood, in conjunction with dehydration. The clinical relevance of the PP:F ratio, however, remains unknown.
Methods Used
Two databases were reviewed to identify 412 hyperfibrinogenemic horses. PP:F ratios were calculated and their interpretation compared to the fibrinogen concentration.
If the PP:F ratio was less than 15, it was generally assumed to indicate inflammation. However, when the ratio was equal to or above 15, the albumin and total protein concentrations were further analyzed to determine the likelihood of inflammation.
Findings
When comparing the PP:F ratios with fibrinogen concentration, 86% agreement was identified in diagnosing the presence of inflammation.
In instances where the PP:F ratios did not support the presence of inflammation (around 72% of cases), inflammation was still deemed likely based on observations of the total albumin and protein concentrations.
Ultimately, it was concluded that the PP:F ratios do not generally provide additional information in horses beyond the simple measurements of fibrinogen concentrations.
Cite This Article
APA
Fernandez NJ, Roy MF.
(2019).
Do plasma protein:fibrinogen ratios in horses provide additional information compared with fibrinogen concentration alone?
Can Vet J, 60(6), 625-629.
Department of Veterinary Pathology, Western College of Veterinary Medicine, 1642-52 Campus Drive, Saskatoon, Saskatchewan S7N 5B4 (Fernandez); Veterinary Clinical and Diagnostic Sciences, University of Calgary Faculty of Veterinary Medicine, 3280 Hospital Drive NW, Calgary, Alberta T2N 4Z6 (Roy).
Roy, Marie-France
Department of Veterinary Pathology, Western College of Veterinary Medicine, 1642-52 Campus Drive, Saskatoon, Saskatchewan S7N 5B4 (Fernandez); Veterinary Clinical and Diagnostic Sciences, University of Calgary Faculty of Veterinary Medicine, 3280 Hospital Drive NW, Calgary, Alberta T2N 4Z6 (Roy).
Schalm OW, Smith R, Kaneko JJ. Plasma protein:fibrinogen ratios in dogs, cattle and horses. Part 1. Influence of age on normal values and explanation of use in disease.. California Vet 1970 Feb;:9–11.
Schalm OW. Plasma protein:fibrinogen ratios in disease in the dog and horse — Part II.. California Vet 1970 Apr;:19–22.
Stockham SL, Scott MA. Fundamentals of Veterinary Clinical Pathology. .
Wallace K. Proteins. .
Thrall MA, Weiser G, Allison R, Campbell T. Veterinary Hematology and Clinical Chemistry. .
Latimer KS. Duncan and Prasse’s Veterinary Laboratory Medicine: Clinical Pathology. .
Feldman BF, Joseph GZ, Jain NC. Schalm’s Veterinary Hematology. .
Hodgson J. Protein, hyperfibrinogenemia. .
eClinPathcom Online Textbook. Cornell University; [Last accessed April 9, 2019]. Available from: http://www.eclinpath.com/hemostasis/tests/fibrinogen/
Schalm OW. Plasma protein:fibrinogen ratios in routine clinical material from cats, dogs, horses, and cattle — Part III.. California Vet 1970 Jun;:6–10.
Andrews DA, Reagan WJ, DeNicola DB. Plasma-fibrinogen in recognizing equine inflammatory disease.. Compend Contin Educ Pract Vet 1994;16:1349–1356.